These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32763784)

  • 1. Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? an international multicenter analysis.
    Bergamini A; Sarwar N; Ferrandina G; Scarfone G; Short D; Aguiar X; Camnasio C; Kaur B; Savage PM; Cormio G; Lim A; Pignata S; Mangili G; Seckl MJ
    Eur J Cancer; 2020 Sep; 137():136-143. PubMed ID: 32763784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of staging surgery and adjuvant chemotherapy in adult patients with apparent stage I pure immature ovarian teratoma after fertility-sparing surgery.
    Wang D; Zhu S; Jia C; Cao D; Wu M; Shen K; Yang J; Xiang Y
    Int J Gynecol Cancer; 2020 May; 30(5):664-669. PubMed ID: 32179695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors for pure ovarian immature teratoma and the role of adjuvant chemotherapy in stage I diseases.
    Li S; Zhang X; Zhang T; Yin M; Cao D; Xiang Y; Yang J
    Ann Med; 2023; 55(2):2273984. PubMed ID: 37909181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study.
    Mangili G; Sigismondi C; Lorusso D; Cormio G; Candiani M; Scarfone G; Mascilini F; Gadducci A; Mosconi AM; Scollo P; Cassani C; Pignata S; Ferrandina G
    Ann Oncol; 2017 Feb; 28(2):333-338. PubMed ID: 27803008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9).
    Mangili G; Scarfone G; Gadducci A; Sigismondi C; Ferrandina G; Scibilia G; Viganò R; Tateo S; Villa A; Lorusso D
    Gynecol Oncol; 2010 Oct; 119(1):48-52. PubMed ID: 20599258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance alone in stage I malignant ovarian germ cell tumors: a MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study.
    Mangili G; Giorda G; Ferrandina G; Cormio G; Cassani C; Savarese A; Danese S; Carnelli M; Vasta FM; Perrone AM; Scarfone G; Pignata S; Legge F; Raspagliesi F; Taccagni G; Candiani M; Bogani G; Mascilini F; Bergamini A
    Int J Gynecol Cancer; 2021 Sep; 31(9):1242-1247. PubMed ID: 34035080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic comparison of active surveillance and adjuvant chemotherapy in the treatment of patients with stage Ⅰ ovarian immature teratoma after fertility-sparing surgery].
    Zhang XY; Yang J; Xiang Y; Wu M; Pan LY; Yang JX
    Zhonghua Fu Chan Ke Za Zhi; 2023 Nov; 58(11):838-845. PubMed ID: 37981770
    [No Abstract]   [Full Text] [Related]  

  • 8. Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative.
    Pashankar F; Hale JP; Dang H; Krailo M; Brady WE; Rodriguez-Galindo C; Nicholson JC; Murray MJ; Bilmire DF; Stoneham S; Arul GS; Olson TA; Stark D; Shaikh F; Amatruda JF; Covens A; Gershenson DM; Frazier AL
    Cancer; 2016 Jan; 122(2):230-7. PubMed ID: 26485622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pure Immature Teratoma of the Ovary in Adults: Thirty-Year Experience of a Single Tertiary Care Center.
    Alwazzan AB; Popowich S; Dean E; Robinson C; Lotocki R; Altman AD
    Int J Gynecol Cancer; 2015 Nov; 25(9):1616-22. PubMed ID: 26332392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance Only for High-risk FIGO Stage IA/IB Malignant Ovarian Germ Cell Tumors: Results From a National Cancer Database.
    Nasioudis D; Frey MK; Chapman-Davis E; Caputo TA; Holcomb KM
    Am J Clin Oncol; 2021 May; 44(5):195-199. PubMed ID: 33710136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of patients with stage I immature teratoma after surveillance or adjuvant chemotherapy.
    Marino G; Grassi T; De Ponti E; Negri S; Testa F; Giuliani D; Delle Marchette M; Dell'Oro C; Fumagalli D; Donatiello G; Besana G; Marchetta L; Bonazzi CM; Lissoni AA; Landoni F; Fruscio R
    Front Oncol; 2024; 14():1330481. PubMed ID: 38371620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pure pediatric ovarian immature teratomas: The French experience.
    Pavone R; Dijoud F; Galmiche L; Ro V; Hameury F; Sarnacki S; Orbach D; Briandet C; Pasquet M; Bertrand A; Fresneau B; Faure-Conter C
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28186. PubMed ID: 31981415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network.
    Derquin F; Floquet A; Hardy-Bessard AC; Edeline J; Lotz JP; Alexandre J; Pautier P; Angeles MA; Delanoy N; Lefeuvre-Plesse C; Cancel M; Treilleux I; Augereau P; Lavoue V; Kalbacher E; Berton Rigaud D; Selle F; Nadeau C; Gantzer J; Joly F; Guillemet C; Pomel C; Favier L; Abdeddaim C; Venat-Bouvet L; Provansal M; Fabbro M; Kaminsky MC; Lortholary A; Lecuru F; Coquard IR; de La Motte Rouge T
    Gynecol Oncol; 2020 Sep; 158(3):666-672. PubMed ID: 32624235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results from a Monocentric Long-Term Analysis of 23 Patients with Ovarian Sertoli-Leydig Cell Tumors.
    Gouy S; Arfi A; Maulard A; Pautier P; Bentivegna E; Leary A; Chargari C; Genestie C; Morice P
    Oncologist; 2019 May; 24(5):702-709. PubMed ID: 30201740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: 'Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? An international multicenter analysis'.
    Lockley M; Stoneham S; Shamash J; Pashankar F; Frazier L
    Eur J Cancer; 2021 Jul; 152():255-256. PubMed ID: 34099362
    [No Abstract]   [Full Text] [Related]  

  • 16. Response to letter entitled: Re: Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? An international multicenter analysis.
    Bergamini A; Sarwar N; Ferrandina G; Scarfone G; Short D; Aguiar X; Camnasio C; Kaur B; Savage PM; Cormio G; Lim A; Pignata S; Mangili G; Seckl MJ
    Eur J Cancer; 2021 Jul; 152():257-258. PubMed ID: 34112565
    [No Abstract]   [Full Text] [Related]  

  • 17. Management strategy for children with ovarian immature teratoma: results from a tertiary pediatric oncology center.
    Ahmed G; Khalil SA; Elshafiey M; Abdelfattah N; Eid M; Zakaria AS; Elwakeel M; Elgendy A
    World J Surg Oncol; 2024 Jul; 22(1):176. PubMed ID: 38965563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric ovarian immature teratoma: Histological grading and clinical characteristics.
    Shinkai T; Masumoto K; Chiba F; Shirane K; Tanaka Y; Aiyoshi T; Sasaki T; Ono K; Gotoh C; Urita Y; Takayasu H; Suzuki R; Sakashita S
    J Pediatr Surg; 2020 Apr; 55(4):707-710. PubMed ID: 31130350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian immature teratoma: treatment and outcome in a single institutional cohort.
    Vicus D; Beiner ME; Clarke B; Klachook S; Le LW; Laframboise S; Mackay H
    Gynecol Oncol; 2011 Oct; 123(1):50-3. PubMed ID: 21764111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pure ovarian immature teratoma, a unique and curable disease: 10 years' experience of 32 prospectively treated patients.
    Bonazzi C; Peccatori F; Colombo N; Lucchini V; Cantù MG; Mangioni C
    Obstet Gynecol; 1994 Oct; 84(4):598-604. PubMed ID: 7522313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.